nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—Irbesartan—JUN—liver cancer	0.0601	0.776	CrCbGaD
Tasosartan—Valsartan—ALB—liver cancer	0.0116	0.15	CrCbGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00729	0.0079	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00706	0.00765	CbGpPWpGaD
Tasosartan—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00703	0.00762	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR4—liver cancer	0.007	0.00759	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00694	0.00752	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—TRIO—liver cancer	0.00663	0.00718	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.0065	0.00705	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00649	0.00704	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR4—liver cancer	0.00636	0.00689	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—CTNNB1—liver cancer	0.00628	0.0068	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00618	0.0067	CbGpPWpGaD
Tasosartan—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00588	0.00637	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—liver cancer	0.00583	0.00632	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—liver cancer	0.00569	0.00617	CbGpPWpGaD
Tasosartan—Losartan—ALB—liver cancer	0.00569	0.0734	CrCbGaD
Tasosartan—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00565	0.00613	CbGpPWpGaD
Tasosartan—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00562	0.0061	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.0053	0.00574	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SHC3—liver cancer	0.00529	0.00573	CbGpPWpGaD
Tasosartan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00505	0.00547	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—F2—liver cancer	0.00495	0.00537	CbGpPWpGaD
Tasosartan—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00485	0.00525	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PRKCE—liver cancer	0.00461	0.00499	CbGpPWpGaD
Tasosartan—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.0046	0.00498	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—liver cancer	0.00451	0.00488	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00448	0.00486	CbGpPWpGaD
Tasosartan—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.0044	0.00477	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CASP3—liver cancer	0.0043	0.00466	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2—liver cancer	0.00429	0.00465	CbGpPWpGaD
Tasosartan—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00422	0.00458	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00412	0.00447	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—liver cancer	0.00411	0.00445	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FST—liver cancer	0.0041	0.00445	CbGpPWpGaD
Tasosartan—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00406	0.0044	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR4—liver cancer	0.00404	0.00437	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PRKCE—liver cancer	0.00403	0.00437	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TRIO—liver cancer	0.00392	0.00424	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00385	0.00417	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR4—liver cancer	0.00375	0.00407	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PRKCE—liver cancer	0.00366	0.00397	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—liver cancer	0.00365	0.00395	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00363	0.00394	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CSF2—liver cancer	0.00356	0.00386	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—liver cancer	0.00335	0.00364	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—liver cancer	0.00335	0.00363	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—UGDH—liver cancer	0.0033	0.00358	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CSF2—liver cancer	0.00324	0.00351	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—F2—liver cancer	0.0032	0.00347	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—F2—liver cancer	0.00316	0.00342	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—liver cancer	0.00313	0.00339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHN2—liver cancer	0.00307	0.00333	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00302	0.00327	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADAM17—liver cancer	0.00297	0.00322	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00286	0.0031	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IFT88—liver cancer	0.00281	0.00305	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—F2—liver cancer	0.0028	0.00303	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PSMA4—liver cancer	0.00279	0.00302	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PSMD10—liver cancer	0.00279	0.00302	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CG—liver cancer	0.00268	0.0029	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—F2—liver cancer	0.00254	0.00275	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00253	0.00274	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00244	0.00265	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CG—liver cancer	0.00243	0.00263	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00241	0.00261	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—TRIO—liver cancer	0.00238	0.00258	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CD—liver cancer	0.00235	0.00255	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR4—liver cancer	0.00228	0.00247	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00217	0.00235	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCE—liver cancer	0.00216	0.00234	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TRIO—liver cancer	0.00216	0.00234	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00215	0.00233	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CD—liver cancer	0.00214	0.00232	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00212	0.0023	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00209	0.00226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR4—liver cancer	0.00207	0.00224	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CB—liver cancer	0.00205	0.00222	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF2—liver cancer	0.00205	0.00222	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00198	0.00215	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.00193	0.00209	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CSF2—liver cancer	0.00191	0.00207	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—RAF1—liver cancer	0.00191	0.00207	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.0019	0.00206	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—H2AFX—liver cancer	0.00188	0.00204	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—liver cancer	0.00188	0.00204	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.00187	0.00203	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CB—liver cancer	0.00186	0.00202	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00175	0.0019	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.00174	0.00188	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00173	0.00188	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SHC3—liver cancer	0.00172	0.00187	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.00171	0.00186	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—liver cancer	0.00171	0.00185	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TERT—liver cancer	0.0017	0.00185	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.00169	0.00183	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.00163	0.00177	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—NAT2—liver cancer	0.00161	0.00175	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—F2—liver cancer	0.00161	0.00175	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00159	0.00172	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—liver cancer	0.00156	0.00169	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK14—liver cancer	0.00155	0.00168	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ESR1—liver cancer	0.00152	0.00165	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—F2—liver cancer	0.0015	0.00163	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—liver cancer	0.00144	0.00156	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—liver cancer	0.00144	0.00156	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—liver cancer	0.00143	0.00155	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00142	0.00154	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00139	0.00151	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.00135	0.00147	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BRAF—liver cancer	0.00135	0.00146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FST—liver cancer	0.00134	0.00145	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCE—liver cancer	0.00131	0.00142	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.00129	0.0014	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00128	0.00139	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TRIO—liver cancer	0.00128	0.00138	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CD—liver cancer	0.00126	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—liver cancer	0.00125	0.00136	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—liver cancer	0.00125	0.00135	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—liver cancer	0.00124	0.00134	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR4—liver cancer	0.00122	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCE—liver cancer	0.00119	0.00129	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00118	0.00128	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CSF2—liver cancer	0.00116	0.00126	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—liver cancer	0.00114	0.00123	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.00113	0.00123	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RAF1—liver cancer	0.00113	0.00122	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CB—liver cancer	0.0011	0.00119	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTOR—liver cancer	0.0011	0.00119	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CSF2—liver cancer	0.00105	0.00114	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.00105	0.00114	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—liver cancer	0.00105	0.00114	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00104	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—liver cancer	0.00103	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—liver cancer	0.00102	0.00111	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—liver cancer	0.00101	0.0011	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—liver cancer	0.00101	0.0011	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—liver cancer	0.00101	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—liver cancer	0.000985	0.00107	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—liver cancer	0.000983	0.00107	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CTNNB1—liver cancer	0.000976	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADAM17—liver cancer	0.000967	0.00105	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000965	0.00105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—liver cancer	0.000956	0.00104	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—liver cancer	0.000953	0.00103	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK8—liver cancer	0.00093	0.00101	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—liver cancer	0.000928	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2—liver cancer	0.000911	0.000988	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSMA4—liver cancer	0.000909	0.000985	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSMD10—liver cancer	0.000909	0.000985	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—liver cancer	0.000872	0.000945	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000867	0.00094	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—liver cancer	0.000859	0.000931	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000855	0.000927	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—liver cancer	0.00085	0.000922	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2—liver cancer	0.000828	0.000897	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000797	0.000864	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—liver cancer	0.000792	0.000859	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—liver cancer	0.00079	0.000856	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—liver cancer	0.000788	0.000854	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000786	0.000852	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CD—liver cancer	0.000767	0.000831	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000755	0.000819	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000745	0.000808	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—liver cancer	0.00073	0.000791	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCE—liver cancer	0.000704	0.000763	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CD—liver cancer	0.000696	0.000755	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—liver cancer	0.000671	0.000727	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CB—liver cancer	0.000668	0.000724	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—liver cancer	0.000667	0.000723	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—liver cancer	0.000649	0.000703	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSF2—liver cancer	0.000623	0.000675	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RAF1—liver cancer	0.000622	0.000674	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—liver cancer	0.000621	0.000673	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H2AFX—liver cancer	0.000614	0.000666	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—liver cancer	0.000614	0.000665	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CB—liver cancer	0.000607	0.000658	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—liver cancer	0.000594	0.000644	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UGDH—liver cancer	0.000565	0.000612	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—liver cancer	0.000557	0.000604	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TERT—liver cancer	0.000555	0.000602	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—liver cancer	0.000548	0.000594	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EPT1—liver cancer	0.000531	0.000576	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—liver cancer	0.000508	0.000551	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK14—liver cancer	0.000505	0.000547	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TAT—liver cancer	0.000504	0.000546	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ESR1—liver cancer	0.000495	0.000537	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2—liver cancer	0.000489	0.00053	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—liver cancer	0.000468	0.000507	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—liver cancer	0.000468	0.000507	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—liver cancer	0.00044	0.000477	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CD—liver cancer	0.000411	0.000446	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000407	0.000442	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—liver cancer	0.000407	0.000441	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—liver cancer	0.000403	0.000437	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—liver cancer	0.00037	0.000401	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAF1—liver cancer	0.000367	0.000398	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—liver cancer	0.000359	0.000389	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CB—liver cancer	0.000359	0.000389	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—liver cancer	0.000342	0.000371	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CPT1B—liver cancer	0.000342	0.000371	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLUL—liver cancer	0.000342	0.000371	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—liver cancer	0.000336	0.000365	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—liver cancer	0.000333	0.000361	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NR1H4—liver cancer	0.00033	0.000358	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—liver cancer	0.00033	0.000357	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—liver cancer	0.000329	0.000357	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—liver cancer	0.000328	0.000355	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA3—liver cancer	0.000324	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—liver cancer	0.000321	0.000348	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—liver cancer	0.00032	0.000347	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNB1—liver cancer	0.000318	0.000345	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—liver cancer	0.000312	0.000338	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—liver cancer	0.000311	0.000337	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK8—liver cancer	0.000303	0.000329	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—liver cancer	0.000302	0.000328	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA4—liver cancer	0.000297	0.000322	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA2—liver cancer	0.000289	0.000313	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—liver cancer	0.00028	0.000303	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA1—liver cancer	0.000279	0.000302	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—liver cancer	0.000277	0.0003	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NAT2—liver cancer	0.000276	0.000299	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDOB—liver cancer	0.000265	0.000287	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—liver cancer	0.000257	0.000279	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—liver cancer	0.000257	0.000278	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CRABP1—liver cancer	0.000252	0.000274	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—liver cancer	0.000238	0.000258	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HPGDS—liver cancer	0.000221	0.000239	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—liver cancer	0.000219	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—liver cancer	0.000211	0.000229	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—liver cancer	0.000202	0.000219	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PSMA4—liver cancer	0.000197	0.000213	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PSMD10—liver cancer	0.000197	0.000213	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—liver cancer	0.000194	0.00021	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GOT2—liver cancer	0.000191	0.000207	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2E1—liver cancer	0.00018	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—liver cancer	0.000179	0.000194	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYCS—liver cancer	0.000168	0.000182	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GOT1—liver cancer	0.000165	0.000179	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GGT1—liver cancer	0.000165	0.000179	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—liver cancer	0.000148	0.000161	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—liver cancer	0.000146	0.000159	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—liver cancer	0.000136	0.000148	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A1—liver cancer	0.000129	0.00014	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—liver cancer	0.00012	0.000131	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARA—liver cancer	0.000118	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—liver cancer	0.000101	0.00011	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—liver cancer	9.77e-05	0.000106	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CD—liver cancer	8.9e-05	9.64e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—liver cancer	8.78e-05	9.52e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CB—liver cancer	7.75e-05	8.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—liver cancer	4.73e-05	5.12e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—liver cancer	3.86e-05	4.19e-05	CbGpPWpGaD
